S-2339-119
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Sponsored by Amy Klobuchar (D-MN)
What it does
This bill would reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young (EARLY) Act of 2009 by extending its funding authorization from 2026 to 2031. The original law directs the CDC to run public education campaigns about breast health and breast cancer risk for women under 40, and to award grants to community organizations for outreach. This bill would allow those activities to continue for five additional years.
Who benefits
Young women under 40, particularly those at elevated risk for early-onset breast cancer, who would continue to receive education and awareness outreach. Community health organizations and nonprofits that receive CDC grants under the program. Healthcare providers who benefit from patients arriving with greater awareness of symptoms. Medically underserved communities that rely on federally funded outreach for health information they may not otherwise receive.
Who is hurt
There are no direct groups harmed by this bill. Indirectly, other public health programs competing for discretionary funding within the same budget accounts could face opportunity costs if appropriators prioritize this program. Taxpayers bear the cost of continued program funding, though the specific dollar amount depends on future appropriations decisions.
Supporters argue
Supporters argue that breast cancer is the most commonly diagnosed cancer among women under 40, and that early detection dramatically improves survival rates — the five-year survival rate for localized breast cancer exceeds 99%, compared to 29% for metastatic disease. They contend that the EARLY Act fills a specific gap because standard mammography screening guidelines do not apply to most women under 40, making community education the primary tool for early detection in this age group.
Opponents argue
Opponents argue that reauthorizing the program without a formal evaluation of its effectiveness is poor fiscal stewardship, as there is limited published evidence that the EARLY Act's awareness campaigns have produced measurable improvements in early detection rates or health outcomes among young women. They contend that Congress should require outcome-based performance metrics before extending any program, and that discretionary health dollars may produce greater benefit if directed toward programs with stronger evidence bases.